New directions in migraine

Weir, G. A. and Cader, M. Z. (2011) New directions in migraine. BMC Medicine, 9, 116. (doi: 10.1186/1741-7015-9-116) (PMID:22027350) (PMCID:PMC3217871)

197658.pdf - Published Version
Available under License Creative Commons Attribution.



Migraine is a highly prevalent neurological disorder imparting a major burden on health care around the world. The primary pathology may be a state of hyperresponsiveness of the nervous system, but the molecular mechanisms are yet to be fully elucidated. We could now be at a watershed moment in this respect, as the genetic loci associated with typical forms of migraine are being revealed. The genetic discoveries are the latest step in the evolution of our understanding of migraine, which was initially considered a cerebrovascular condition, then a neuroinflammatory process and now primarily a neurogenic disorder. Indeed, the genetic findings, which have revealed ion channels and transporter mutations as causative of migraine, are a powerful argument for the neurogenic basis of migraine. Modulations of ion channels leading to amelioration of the migraine 'hyperresponsive' brain represent attractive targets for drug discovery. There lies ahead an exciting and rapidly progressing phase of migraine translational research, and in this review we highlight recent genetic findings and consider how these may affect the future of migraine neurobiology and therapy.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Weir, Dr Gregory
Authors: Weir, G. A., and Cader, M. Z.
College/School:College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience
Journal Name:BMC Medicine
Publisher:BioMed Central
ISSN (Online):1741-7015
Copyright Holders:Copyright © 2011 Weir and Cader
First Published:First published in BMC Medicine 9: 116
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record